Displaying 1 - 50 of 132 results
Released Company Title Industry Topic
26 Feb 2021
08:00 CET
ACACIA PHARMA Issue of Equity on Exercise of Options/Vesting of Performance Share Awards 20103010 Biotechnology Other subject
26 Feb 2021
08:00 CET
ACACIA PHARMA Transparency Notification 20103010 Biotechnology Other subject
23 Feb 2021
08:00 CET
ACACIA PHARMA Admission to Trading on Euronext Brussels 20103010 Biotechnology Other subject
19 Feb 2021
08:00 CET
ACACIA PHARMA Results of Placing – EUR 27 million Raised to Invest Further in US Launch and Commercialization Activities 20103010 Biotechnology Other subject
18 Feb 2021
13:15 CET
ACACIA PHARMA Proposed Capital Raising by way of a Placing of New Ordinary Shares and Update on Early Positive Market Reception to US Launch of BARHEMSYS® 20103010 Biotechnology Other subject
18 Feb 2021
09:00 CET
ACACIA PHARMA  Change of EU home Member State 20103010 Biotechnology Other subject
12 Feb 2021
07:00 CET
ACACIA PHARMA Issue of Equity on Exercise of Options/Vesting of Performance Share Awards 20103010 Biotechnology Other subject
04 Feb 2021
07:00 CET
ACACIA PHARMA Issue of Equity on Exercise of Options/Vesting of Performance Share Awards 20103010 Biotechnology Other subject
28 Jan 2021
07:00 CET
ACACIA PHARMA Acacia Pharma Launches BYFAVO™ (remimazolam) in the United States for Procedural Sedation in Adults Undergoing Medical Procedures Lasting 30 Minutes or Less 20103010 Biotechnology Other subject
21 Jan 2021
13:00 CET
ACACIA PHARMA Acacia Pharma to present at the Upcoming Degroof Petercam Virtual Healthcare Conference 20103010 Biotechnology Other subject
20 Jan 2021
11:40 CET
ACACIA PHARMA Issue of Equity on Exercise of Options/Vesting of Performance Share Awards 20103010 Biotechnology Other subject
20 Jan 2021
08:00 CET
ACACIA PHARMA Acacia Pharma wins BEL Small Company of the Year for the second consecutive year 20103010 Biotechnology Other subject
18 Dec 2020
13:45 CET
ACACIA PHARMA Holding(s) in Company 20103010 Biotechnology Other subject
18 Dec 2020
13:18 CET
ACACIA PHARMA Holding(s) in Company 20103010 Biotechnology Other subject
18 Dec 2020
13:17 CET
ACACIA PHARMA Holding(s) in Company 20103010 Biotechnology Other subject
18 Dec 2020
11:04 CET
ACACIA PHARMA Admission to Trading on Euronext Brussels 20103010 Biotechnology Other subject
17 Dec 2020
11:14 CET
ACACIA PHARMA Publication of Supplementary Prospectus 20103010 Biotechnology Other subject
15 Dec 2020
09:07 CET
ACACIA PHARMA Correction: Acacia Pharma Announces Amendment of its Investment Agreement with Cosmo Pharmaceuticals for BYFAVO™ 20103010 Biotechnology Other subject
15 Dec 2020
07:46 CET
ACACIA PHARMA Acacia Pharma Announces Amendment of its Investment Agreement with Cosmo Pharmaceuticals for BYFAVO™ 20103010 Biotechnology Other subject
13 Oct 2020
09:12 CEST
ACACIA PHARMA Director/PDMR Shareholding 20103010 Biotechnology Other subject
13 Oct 2020
09:10 CEST
ACACIA PHARMA Director/PDMR Shareholding 20103010 Biotechnology Other subject
13 Oct 2020
09:06 CEST
ACACIA PHARMA Issue of Shares to Employee Benefit Trust 20103010 Biotechnology Other subject
09 Oct 2020
07:00 CEST
ACACIA PHARMA Acacia Pharma completes drawdown from €25 million loan facility from Cosmo Pharmaceuticals to support US launches of BARHEMSYS® and BYFAVO™ 20103010 Biotechnology Other subject
06 Oct 2020
16:45 CEST
ACACIA PHARMA Acacia Pharma announces BYFAVO™ (remimazolam), its Newly Approved Product for Procedural Sedation, Clears Final Hurdle on Path to Commercial Launch in the US 20103010 Biotechnology Other subject
24 Aug 2020
07:00 CEST
ACACIA PHARMA BARHEMSYS® (amisulpride injection) Launched in the US for the Treatment and Prevention of PONV 20103010 Biotechnology Other subject
19 Aug 2020
12:16 CEST
ACACIA PHARMA Holding(s) in Company 20103010 Biotechnology Other subject
19 Aug 2020
12:14 CEST
ACACIA PHARMA Holding(s) in Company 20103010 Biotechnology Other subject
19 Aug 2020
12:10 CEST
ACACIA PHARMA Holding(s) in Company 20103010 Biotechnology Other subject
18 Aug 2020
08:01 CEST
ACACIA PHARMA Admission to Trading on Euronext Brussels 20103010 Biotechnology Other subject
14 Aug 2020
13:25 CEST
ACACIA PHARMA Publication of Prospectus 20103010 Biotechnology Other subject
14 Aug 2020
08:00 CEST
ACACIA PHARMA Results of Placing 20103010 Biotechnology Other financial transaction
13 Aug 2020
15:01 CEST
ACACIA PHARMA Proposed Capital Raising by way of a Placing of New Ordinary Shares 20103010 Biotechnology Other financial transaction
13 Aug 2020
15:00 CEST
ACACIA PHARMA Interim Results for the Six Months ended 30 June 2020 20103010 Biotechnology Other subject
27 Jul 2020
07:00 CEST
ACACIA PHARMA Acacia Pharma Advances Preparations for US Launch of BARHEMSYS® 20103010 Biotechnology Other subject
21 Jul 2020
12:43 CEST
ACACIA PHARMA Holding(s) in Company 20103010 Biotechnology Other subject
21 Jul 2020
12:38 CEST
ACACIA PHARMA Holding(s) in Company 20103010 Biotechnology Other subject
21 Jul 2020
12:34 CEST
ACACIA PHARMA Holding(s) in Company 20103010 Biotechnology Other subject
16 Jul 2020
13:48 CEST
ACACIA PHARMA Issue of Equity pursuant to Sub-Licensing Agreement With Cosmo Technologies 20103010 Biotechnology Other subject
15 Jul 2020
07:00 CEST
ACACIA PHARMA Acacia Pharma Assigned US License for BYFAVO™ (remimazolam) by Cosmo Pharmaceuticals NV 20103010 Biotechnology Other subject
02 Jul 2020
20:02 CEST
ACACIA PHARMA Acacia Pharma Announces US FDA Approval of BYFAVO™ (remimazolam) for injection for the Induction and Maintenance of Procedural Sedatio 20103010 Biotechnology Other subject
08 Jun 2020
11:01 CEST
ACACIA PHARMA TR-1: Standard form for notification of major holdings 20103010 Biotechnology Other subject
04 Jun 2020
11:03 CEST
ACACIA PHARMA TR-1: Standard form for notification of major holdings 20103010 Biotechnology Other subject
04 Jun 2020
10:59 CEST
ACACIA PHARMA TR-1: Standard form for notification of major holdings 20103010 Biotechnology Other subject
01 Jun 2020
07:00 CEST
ACACIA PHARMA Acacia Pharma Announces Debt for Equity Swap with Cosmo Pharmaceuticals 20103010 Biotechnology Other subject
08 May 2020
07:00 CEST
ACACIA PHARMA Issue of Equity on Exercise of Options/Vesting of Performance Share Awards Pharmaceuticals Other subject
07 May 2020
07:00 CEST
ACACIA PHARMA Issue of Equity on Exercise of Options/Vesting of Performance Share Awards Pharmaceuticals Other subject
07 Apr 2020
23:19 CEST
ACACIA PHARMA Alessandro Della Chà appointed as Director of Acacia Pharma Group plc Pharmaceuticals Other subject
07 Apr 2020
23:15 CEST
ACACIA PHARMA Results of Annual General Meeting Pharmaceuticals Other subject
24 Mar 2020
18:36 CET
ACACIA PHARMA Publication of Prospectus Pharmaceuticals Other subject
23 Mar 2020
10:00 CET
ACACIA PHARMA Forthcoming 2020 Annual General Meeting – Change of Venue and Proxy Forms Pharmaceuticals Other subject